Role of hypertriglycerydemia in cardiovascular diseases – an update Review article
Article Sidebar
Main Article Content
Abstract
In the recent years increased serum triglyceride level accompanying obesity and the states of insulin resistance is observed. Independent relationship of high triglycerides with cardiovascular risk is still controversial but elevated triglyceride-rich lipoproteins level has been considered as atherogenic factor, which correlates with the incidence of cardiovascular events. Triglycerides <150 mg/dl is an important parameter of „cardiometabolic health”. However, clinical trials with lipid-lowering therapy haven’t shown yet clearly that the reduction in triglycerides reduced the cardiovascular risk. The full explanation of this problem requires big, well-designed clinical trials performed in the nearest future.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. Chapman M., Ginsberg H., Amarenco P. et al. for the European Atherosclerosis Society Consensus Panel: Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur. Heart J. 2011 [DOI: 10.1093/eurheartj/ehr112].